Free shipping on all orders over $ 500

 About 2 results found for searched term "GDC-0994" (0.126 seconds)

Cat.No.  Name Target
M3668 GDC-0994 ERK
Ravoxertinib
Ravoxertinib (GDC-0994) is an orally active ERK kinase inhibitor with IC50 of 6.1 nM and 3.1 nM against ERK1 and ERK2, respectively.
M14153 Ravoxertinib hydrochloride ERK
GDC-0994 hydrochloride
Ravoxertinib hydrochloride (GDC-0994 hydrochloride) is an orally bioavailable inhibitor selective for ERK kinase activity with IC50 of 6.1 nM and 3.1 nM for ERK1 and ERK2, respectively.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.